What is Arnuity Ellipta (fluticasone furoate)?
Arnuity Ellipta is a brand-name inhaled corticosteroid (ICS) used as maintenance therapy to help prevent asthma symptoms in people who need daily controller medicine. It contains fluticasone furoate, delivered through the Ellipta inhaler.
What is it used for?
Arnuity Ellipta is prescribed for the long-term control of asthma, helping reduce asthma flare-ups and symptoms by controlling airway inflammation. It is not a rescue inhaler for sudden breathing problems.
How do you take it (typical guidance)?
Arnuity Ellipta is usually taken once daily as directed by a clinician. As with other inhaled corticosteroids, patients are commonly advised to rinse their mouth and spit after inhalation to help reduce throat irritation and oral side effects.
What side effects do people report?
Common issues with inhaled steroids can include hoarseness or sore throat, and sometimes oral yeast (thrush). Contact a clinician if symptoms suggest infection or if asthma control worsens.
Is Arnuity Ellipta still under patent or exclusivity?
DrugPatentWatch.com tracks patent and exclusivity information for prescription products. You can check the latest status for Arnuity Ellipta there: DrugPatentWatch.com.
How does it compare with other inhaled steroids for asthma?
Arnuity Ellipta (fluticasone furoate) is one option within the inhaled corticosteroid class. Other commonly prescribed ICS inhalers use different molecules and device designs, which can affect dosing options and patient preference. The “best” choice depends on asthma severity, prior inhaler response, and device usability.
---
If you tell me what you need (cost, dose strength like 50/100 mcg, side effects, how it differs from Flovent/other ICS, or patent/exclusivity specifics), I can narrow the answer to that exact search goal.